Home › Cohorts › Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. PC53F1ED9E
3 studies · 620 curated samples · 448 distinct subject identifiers · 1 shared paper. Grouping rule: shared own-data paper.
Age categories
| adult | 593 |
| elderly | 22 |
| adolescent | 5 |
Countries
| CN | 620 |
Health conditions
| healthy_control Healthy / control | 257 |
| autoimmune_inflammatory Autoimmune / inflammatory (RA | 194 |
| liver_disease Liver disease (cirrhosis | 169 |
Studies
| study | title | samples | source |
|---|---|---|---|
| PRJEB6337 | Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Previous studies have shown an association between the gut microbiota and liver complications such as cirrhosis and other liver injuries. We therefore undertook a whole gut microbiome wide association study of stool samples from 98 liver cirrhosis patients and 83 healthy controls to characterise the faecal microbial communities and their functional composition. In total, we generated 860 Gb of high-quality sequence data and built a reference gene set for the liver cirrhosis cohort containing 2.69 million genes, 36.1% of which was not covered by previously published gene catalogues. | 312 | gut_all_v1 |
| PRJNA375935 | human gut Metagenome | 211 | gut_all_v1 |
| PRJNA353560 | Human gut microbiome in AS | 97 | gut_all_v1 |
Shared papers
- Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. — PMID 28750650 · PMC5530561 · doi · studies: PRJEB6337, PRJNA353560, PRJNA375935